-
1Academic Journal
Authors: T. S. Kurina, V. A. Mironova, M. I. Dubrovskaya, H. A. Sarkisyan, N. V. Davidenko, T. V. Zubova, V. G. Shatalov, Т. С. Курина, В. А. Миронова, М. И. Дубровская, Е. А. Саркисян, Н. В. Давиденко, Т. В. Зубова, В. Г. Шаталов
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 70, № 1 (2025); 88-95 ; Российский вестник перинатологии и педиатрии; Том 70, № 1 (2025); 88-95 ; 2500-2228 ; 1027-4065
Subject Terms: колхицинорезистентность, appendectomy, adhesive disease, intestinal obstruction, colchicine, colchicine resistance, аппендектомия, спаечная болезнь, кишечная непроходимость, колхицин
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/2145/1572; Amaryan G., Sarkisian T., Tadevosyan A., Braegger C. Familial Mediterranean fever in Armenian children with inflammatory bowel disease. Front Pediatr. 2024;11:1288523. DOI:10.3389/fped.2023.1288523; Tufan A., Lachmann H.J. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci. 2020;50(SI-2):1591–1610. DOI:10.3906/sag-2008–11; Амарян Г.Г., Саркисян Т.Ф., Тадевосян А.Э. Клинические и генетические особенности васкулитов, ассоциированных с семейной средиземноморской лихорадкой, у детей в Армении. Научно-практическая ревматология. 2020;58(1): 37–41.; Федоров Е.С., Салугина С.О. Семейная средиземноморская лихорадка (периодическая болезнь): история или реальная проблема. Современная ревматология. 2018;12(3): 61–69; Migita K., Izumi Y., Jiuchi Y., Iwanaga N., Kawahara C., Agematsu K., et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016;18:175. DOI:10.1186/s13075–016–1071–5; Lancieri M., Bustaffa M., Palmeri S., Prigione I., Penco F., Papa R., et al. An Update on Familial Mediterranean Fever. Int J Mol Sci. 2023;24(11): 9584. DOI:10.3390/ijms24119584; Schnappauf O., Chae J.J., Kastner D.L., Aksentijevich I. The Pyrin Inflammasome in Health and Disease. Front Immunol. 2019;10:1745. DOI:10.3389/fimmu.2019.01745; Broz P., Pelegrín P., Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020 r;20(3): 143–157. DOI:10.1038/s41577–019–0228–2; Yaşar Bilge Ş., Sarı İ., Solmaz D., Şenel S., Emmungil H., Kılıç L., et al. The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia. Turk J Med Sci. 2019;49(2): 472–477. DOI:10.3906/sag-1809–100; Tanatar A., Karadağ Ş.G., Çakan M., Sönmez H.E., Ayaz N.A. Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever. Mod Rheumatol. 2021;31(1): 219–222. DOI:10.1080/14397595.2020.1719594; d’Annunzio E., Chafai N., Tiret E. Pitfalls in familial mediterranean fever: acute intestinal strangulation/obstruction due to primary adhesions. J Visc Surg. 2011;148(3): e217–9. DOI:10.1016/j.jviscsurg.2011.05.007; Tarantino G., Esposito S., Andreozzi L., Bracci B., D’Errico F., Rigante D. Lung Involvement in Children with Hereditary Autoinflammatory Disorders. Int J Mol Sci. 2016;17(12): 2111. DOI:10.3390/ijms17122111; Yalçinkaya F., Ozen S., Ozçakar Z.B., Aktay N., Cakar N., Düzova A., et al. A New Set of Criteria for the Diagnosis of Familial Mediterranean Fever in Childhood. Rheumatology. 2009;48:395–398. OI: 10.1093/rheumatology/ken509; Varan O., Kucuk H., Babaoglu H., Tecer D., Atas N., Bilici Salman R., et al. Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis. Scand J Rheumatol. 2019;48(4): 315–319. DOI:10.1080/03009742.2018.1558282; Er O., Ugurlu S. Fertilization, reproductive system, and pregnancy in familial Mediterranean fever: Clinical state of art. Mod Rheumatol. 2024;34(2): 265–271. DOI:10.1093/mr/road067; Satiş H., Armağan B., Bodakçi E., Ataş N., Sari A., Yaşar Bilge N.Ş., et al. Colchicine intolerance in FMF patients and primary obstacles for optimal dosing. Turk J Med Sci. 2020;50(5): 1337–1343. DOI:10.3906/sag-2001–261; Dasgeb B., Kornreich D., McGuinn K., Okon L., Brownell I., Sackett D.L. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018;178(2): 350–356. DOI:10.1111/bjd.15896; Özen S., Sag E., Ben-Chetrit E., Gattorno M., Gül A., Hashkes P.J., et al. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach. Rheumatology (Oxford). 2021;60(8): 3799–3808. DOI:10.1093/rheumatology/keaa863; Van der Hilst J.Ch., Moutschen M., Messiaen P., Lauwerys B., Vanderschueren S. Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. Biologics. 2016;10:75–80. DOI:10.2147/ BTT.S102954; Ozen S., Kone-Paut I., Gül A. Colchicine resistance and intolerance in familial Mediterranean fever: Definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47(1): 115–120. DOI:10.1016/ j.semarthrit.2017.03.006